Dual-modal antioxidant and epigenetic synergy attenuates the self-perpetuating senescence cycle in osteoarthritis
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
References (42)
Show source-provided references
1. Osteoarthritis: a disease of the joint as an organ10.1002/art.34453 ↗
2. Osteoarthritis: an update with relevance for clinical practice10.1016/S0140-6736(11)60243-2 ↗
3. Cartilage-targeted drug nanocarriers for osteoarthritis therapy10.1016/j.ijpharm.2024.124843 ↗
4. Comparative phenotypic and molecular profiling of replicative and chemically-induced senescence in articular chondrocytes10.1038/s41420-026-02961-y ↗
5. Synovial inflammatory macrophage-derived extracellular vesicles exacerbate cartilage lesions with a FMRP-selectively sorted manner in osteoarthritis10.1038/s41413-025-00502-4 ↗
6. Ageing and the pathogenesis of osteoarthritis10.1038/nrrheum.2016.65 ↗
7. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis10.1038/s41584-020-00533-7 ↗
8. The bidirectional role of obesity and aging in the pathogenesis of osteoarthritis: molecular mechanisms, epigenetic insights, and therapeutic implications10.2147/JIR.S514521 ↗
9. Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritis10.1016/j.bcp.2015.12.012 ↗
10. RNA modifications in physiology and disease: towards clinical applications10.1038/s41576-023-00645-2 ↗
11. Significance of m(6)A regulatory factor in gene expression and immune function of osteoarthritis10.3389/fphys.2022.918270 ↗
12. Cross-talk between oxidative stress and m(6)A RNA methylation in cancer10.1155/2021/6545728 ↗
13. Oxidative stress and central metabolism pathways impact epigenetic modulation in inflammation and immune response10.1016/j.freeradbiomed.2025.04.004 ↗
14. Redox-sensitive m(6)A regulation in atherosclerosis: METTL3 at the crossroads of mitochondrial quality control and pyroptosis10.1016/j.redox.2025.103918 ↗
15. Lycopene - antioxidant with radioprotective and anticancer properties. A review
16. Lycopene inhibits reactive oxygen species-mediated NF-kappaB signaling and induces apoptosis in pancreatic cancer cells10.3390/nu11040762 ↗
17. Anti-inflammatory activity of beta-Carotene, lycopene and Tri-n-butylborane, a scavenger of reactive oxygen species
18. SIRT3 promotes mitophagy to attenuate fumonisin B1-induced chicken hepatocyte senescence and antagonism of lycopene10.1016/j.jhazmat.2025.139557 ↗
19. Tailoring the properties of double-crosslinked emulsion gels using structural design principles: physical characteristics, stability, and delivery of lycopene10.1016/j.biomaterials.2021.121265 ↗
20. Intra-articular drug delivery: the challenge to extend drug residence time within the joint10.1016/j.tvjl.2010.09.019 ↗
21. WTAP-mediated m(6)A modification of FRZB triggers the inflammatory response via the Wnt signaling pathway in osteoarthritis10.1038/s12276-023-01135-5 ↗
22. WTAP-mediated abnormal m6A modification promotes cancer progression by remodeling the tumor microenvironment: bibliometric and database analyses10.21037/tcr-23-1243 ↗
23. siRNA therapy in osteoarthritis: targeting cellular pathways for advanced treatment approaches
24. Spatiotemporally controlled intelligent hydrogel platform for precision RNA interference therapy in lumbar facet joint osteoarthritis10.1016/j.cej.2025.171460 ↗
25. Multitriggered tumor-responsive drug delivery vehicles based on protein and polypeptide coassembly for enhanced photodynamic tumor ablation10.1002/smll.201602339 ↗
26. Cetuximab-modified human serum albumin nanoparticles Co-Loaded with doxorubicin and MDR1 siRNA for the treatment of drug-resistant breast tumors10.2147/IJN.S332830 ↗
27. Amphiphilic polypeptides obtained by post-polymerization modification of Poly-l-Lysine as systems for combined delivery of paclitaxel and siRNA10.3390/pharmaceutics15041308 ↗
28. Poly-L-Lysine-Lactobionic acid-capped selenium nanoparticles for liver-targeted gene delivery10.3390/ijms23031492 ↗
29. Nanoengineering of stimuli-responsive protein-based biomimetic protocells as versatile drug delivery tools10.1002/chem.201400348 ↗
30. Cartilage-targeting and dual MMP-13/pH responsive theranostic nanoprobes for osteoarthritis imaging and precision therapy10.1016/j.biomaterials.2019.119520 ↗
31. Hallmarks of aging: an expanding universe10.1016/j.cell.2022.11.001 ↗
32. Dyslipidemia and aging: the non-linear association between atherogenic index of plasma (AIP) and aging acceleration10.1186/s12933-025-02695-8 ↗
33. The role of bioactive glass in osteoarthritis treatment and cartilage regeneration10.30919/es1819 ↗
34. Intranasal delivery of PEGylated mesoporous silica nanoparticles for enhanced brain targeting: in vivo evaluation of pharmacokinetics, biodistribution and biocompatibility10.30919/es2173 ↗
35. Bioactive Papaver somniferum extract-loaded polyvinyl alcohol hydrogels for enhanced in vivo wound healing applications10.30919/es1958 ↗
36. Interactions between protein Z and lycopene: a win-win scenario for both security and stability10.1016/j.ijbiomac.2024.139401 ↗
37. Exploring the interaction between three carotenes and HSA by molecular docking and fluorescence spectroscopy
38. Lycopene entrapped in human albumin protects 2'-deoxyguanosine against singlet oxygen damage
39. Serpine1 as a potential therapeutic target in pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome
40. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq10.1038/nature11112 ↗
41. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons10.1016/j.cell.2012.05.003 ↗
42. N(6)-methyladenosine modulates messenger RNA translation efficiency10.1016/j.cell.2015.05.014 ↗